Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
AVE.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: July 30, 2025
Report Source: 2024 Annual Report
Avecho Biotechnology Ltd. Stock Analysis AVE.AX
Australia Health Care Nano Cap Report: Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Read More Avecho Biotechnology Ltd (AVE.AX) Chart
Key Statistics of Avecho Biotechnology Ltd (AVE.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.01Volume
7.17MP/E Ratio (TTM)
-52 Week Range
Market Cap
45.97MAvg. Volume
3.02MDividend Yield
-Financial Metrics & Statements of Avecho Biotechnology Ltd (AVE.AX)
FAQ's for Avecho Biotechnology Ltd (AVE.AX)
- According to Musaffa’s Shariah screening methodology, Avecho Biotechnology Ltd (AVE.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avecho Biotechnology Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Avecho Biotechnology Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Avecho Biotechnology Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Avecho Biotechnology Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Avecho Biotechnology Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.